The "RNA Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Global RNA Analysis Market was ...

Both total RNA and proteins are column-purified in under 25 minutes using a single column. High-quality and high-yield purified RNA is appropriate for NGS, RT-qPCR, and microarrays. This kit uses ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

Better Diversity of miRNA Detected from HeLa Cells using Illumina Small RNA Next Gen Sequencing. Norgen's Total RNA Purification Kit isolates miRNA from HeLa cells with better diversity than a ...

Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.

Image: NIRBA will engage scientists and clinicians from leading institutions like NUS, A*STAR, NTU, and Duke-NUS Medical School, to build strategic ...

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

This study provides a potentially useful investigation into the positive role of BDNF/TrkB signaling in implanted dental pulp stem cells to enhance dentin regeneration in the context of dental caries.

A “Strong Buy” rating from Wall Street indicates that analysts believe a stock has the potential for future price ...

Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein(a) ...

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...